Monographie - Octreotide acetate

Pēdējā atjaunošana :
19/11/2024

Octreotide acetate

Ķīmiskā uzbūve

Oriģinālais nosaukums

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Akroken	Meksika
Badastin	Ekvadora
Bendatreotid	Ēģipte
Cryostatin	Meksika
Gasterina	Argentīna, Čīle
Jintrotide	Peru
Longastatina	Itālija
Nomactril	Meksika
Ocphyl	Kanāda
Octate	Indija
Octide	Indija
Octotide	Ekvadora
Octreotid	Vācija
Octreotida	Spānija
Octreotide	Amerikas Savienotās Valstis, Kanāda, Lielbritānija
Octride	Ekvadora, Kolumbija
Samilstin	Itālija
Sandostatin	Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Argentīna, Austrālija, Austrija, Brazīlija, Čīle, Dānija, Ekvadora, Grieķija, Īrija, Islande, Jaunzēlande, Kanāda, Lielbritānija, Luksemburga, Malaizija, Norvēģija, Polija, Rumānija, Slovēnija, Somija, Spānija, Šveice, Turcija, Ungārija, Vācija, Zviedrija
Sandostatina	Itālija, Portugāle
Sandostatine	Beļģija, Francija, Holande, Maroka, Portugāle
Secrestat	Kolumbija
Siroctid	Beļģija

Literatūras saraksts : Octreotide acetate

	tips	publicēšana
127	Žurnāls	Ripley RG, Ritchie DJ, Holstad SG. Stability of octreotide acetate in polypropylene syringes at 5 and -20°C. Am J Health-Syst Pharm 1995 ; 52: 1910-1911.
294	Žurnāls	Stiles ML, Allen LV, Resztak KE, Prince SJ. Stability of octreotide acetate in polypropylene syringes. Am J Hosp Pharm 1993 ; 50: 2356-2358.
301	Žurnāls	Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
466	Žurnāls	Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM. Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm 1991 ; 48: 2172-2175.
1415	Žurnāls	Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN 1999 ; 23: 67-74.
1508	Žurnāls	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1902	Žurnāls	Walker SE, Wyllie A, Law S. Physical compatibility of pantoprazole with selected medications during simulated Y-site administration. Can J Hosp Pharm 2004 ; 57, 2: 90-96.
2087	Žurnāls	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	Žurnāls	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2108	Žurnāls	Trusley C, Kupiec TC, Trissel LA. Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Int J Pharm Compound 2006 ; 10: 230-232.
2404	Žurnāls	Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med 2000 ; 14: 205-208.
3216	Žurnāls	Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel 2011 ; 44, 1 : 14-18
3408	Žurnāls	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3767	Žurnāls	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3824	Žurnāls	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3828	plakāts	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakāts	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3948	Žurnāls	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4055	Žurnāls	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4086	Laboratorija	Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit Novartis Pharma 2017
4145	Žurnāls	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434	Žurnāls	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4528	Žurnāls	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4603	Žurnāls	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4742	Žurnāls	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.
4768	Žurnāls	Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H. Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school 2023
4801	Žurnāls	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales